# Trevi Therapeutics, Inc.: Form 8-K, filed Jun 17, 2025

- Company: [Trevi Therapeutics, Inc.](/companies/trvi.md) (CIK 1563880)
- Form: 8-K
- Filed: 2025-06-17
- Accepted by EDGAR: Jun 17, 2025, 17:00 ET
- Period: 2025-06-11
- Accession: 0000950170-25-087486
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/trvi-20250611.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1563880/000095017025087486/trvi-20250611.htm

Filed Jun 17, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-087486. Last ingested by Listed: Oct 27, 2026, 17:29 ET. No prices; not investment advice.